Ensuiko Sugar Refining Co., Ltd. is a Japan-based company primarily engaged in the manufacturing and sale of sugar and sugar-related products. Founded in 1920 and headquartered in Tokyo, the company operates through three main business segments: Sugar, Bio, and Others. Its Sugar segment produces and markets refined sugar products including granulated sugar, white sugar, brown sugar, and liquid sugar under various brands. The Bio segment manufactures and sells lactose, fructose, oligosaccharides, and cyclodextrin, which are used in food, beverage, and pharmaceutical applications. The Others segment leases office buildings, including the New ESR Building. Ensuiko serves domestic markets in Japan with an expanding product range catering to both household and industrial clients.
In recent years, the company has undergone significant strategic changes, notably its acquisition by Daito Seito Co., Ltd. from Mitsubishi Corporation in November 2022, marking an important organizational shift. Ensuiko has also seen operational improvements with an upward revision in its earnings forecast for fiscal year 2026, driven by increased demand in the sugar business from inbound tourism, travel, and beverage manufacturers. The company continues to expand its offerings in functional food science ingredients, producing materials such as edible films and sugar-derived additives. Ensuiko remains focused on maintaining stable supply and high-quality refined sugar products while exploring growth through health-conscious product lines like cyclodextrin, which has rising demand due to its diet and health benefits.
Overall, Ensuiko Sugar Refining combines traditional refined sugar production with innovative bio-products and functional food ingredients, supported by recent corporate acquisitions and expanding market demand in Japan. Its operations reflect a blend of legacy manufacturing and strategic growth in health-oriented food segments, headquartered in Tokyo and serving primarily the Japanese market. This positioning supports both its core refined sugar business and emerging bio-science product lines for future expansion.